Dataset Viewer
Auto-converted to Parquet Duplicate
Year
int64
2.02k
2.03k
Data_Period_Type
stringclasses
2 values
Geo_Level
stringclasses
2 values
Geo_Desc
stringclasses
61 values
Brand_Name
stringclasses
16 values
Generic_Name
stringclasses
7 values
Total_Prescribers
float64
1
254k
Total_Claims
float64
11
10.4M
Total_Drug_Cost
float64
7.14k
13B
2,017
Full Year
National
National
Bydureon
Exenatide Microspheres
12,051
69,973
58,939,311.77
2,017
Full Year
National
National
Bydureon Bcise
Exenatide Microspheres
83
93
92,313.54
2,017
Full Year
National
National
Bydureon Pen
Exenatide Microspheres
36,415
322,702
263,003,841.42
2,017
Full Year
National
National
Byetta
Exenatide
19,787
105,273
101,889,463.72
2,017
Full Year
National
National
Saxenda
Liraglutide
3
13
13,671
2,017
Full Year
National
National
Trulicity
Dulaglutide
59,941
812,080
698,497,167.1
2,017
Full Year
National
National
Victoza 2-Pak
Liraglutide
60,160
416,648
264,692,916.45
2,017
Full Year
National
National
Victoza 3-Pak
Liraglutide
81,859
950,191
1,030,321,793.1
2,017
Full Year
National
National
Xultophy 100-3.6
Insulin Degludec/Liraglutide
1,006
2,827
2,924,464.99
2,017
Full Year
State
Alabama
Bydureon
Exenatide Microspheres
237
1,387
1,093,960.88
2,017
Full Year
State
Alabama
Bydureon Pen
Exenatide Microspheres
666
5,902
4,706,637.67
2,017
Full Year
State
Alabama
Byetta
Exenatide
312
1,495
1,442,738.32
2,017
Full Year
State
Alabama
Trulicity
Dulaglutide
1,205
18,621
15,292,872.11
2,017
Full Year
State
Alabama
Victoza 2-Pak
Liraglutide
1,155
9,454
5,970,872.86
2,017
Full Year
State
Alabama
Victoza 3-Pak
Liraglutide
1,570
23,323
23,806,157.85
2,017
Full Year
State
Alabama
Xultophy 100-3.6
Insulin Degludec/Liraglutide
6
14
13,350.43
2,017
Full Year
State
Alaska
Bydureon
Exenatide Microspheres
12
32
31,306.92
2,017
Full Year
State
Alaska
Bydureon Pen
Exenatide Microspheres
39
252
224,539.48
2,017
Full Year
State
Alaska
Byetta
Exenatide
36
117
126,894.48
2,017
Full Year
State
Alaska
Trulicity
Dulaglutide
69
580
535,042.46
2,017
Full Year
State
Alaska
Victoza 2-Pak
Liraglutide
110
536
324,946.46
2,017
Full Year
State
Alaska
Victoza 3-Pak
Liraglutide
157
954
1,086,941.64
2,017
Full Year
State
Arizona
Bydureon
Exenatide Microspheres
216
960
894,821.01
2,017
Full Year
State
Arizona
Bydureon Pen
Exenatide Microspheres
699
4,861
4,072,539.62
2,017
Full Year
State
Arizona
Byetta
Exenatide
419
2,038
1,969,650.18
2,017
Full Year
State
Arizona
Trulicity
Dulaglutide
1,030
11,131
10,301,858.74
2,017
Full Year
State
Arizona
Victoza 2-Pak
Liraglutide
1,203
8,470
5,684,527.72
2,017
Full Year
State
Arizona
Victoza 3-Pak
Liraglutide
1,425
12,712
14,626,115.9
2,017
Full Year
State
Arizona
Xultophy 100-3.6
Insulin Degludec/Liraglutide
15
29
30,264.77
2,017
Full Year
State
Arkansas
Bydureon
Exenatide Microspheres
121
679
515,604.01
2,017
Full Year
State
Arkansas
Bydureon Pen
Exenatide Microspheres
314
2,682
1,940,543.48
2,017
Full Year
State
Arkansas
Byetta
Exenatide
115
616
527,961.86
2,017
Full Year
State
Arkansas
Trulicity
Dulaglutide
535
5,866
4,522,346.87
2,017
Full Year
State
Arkansas
Victoza 2-Pak
Liraglutide
646
5,055
3,026,088.97
2,017
Full Year
State
Arkansas
Victoza 3-Pak
Liraglutide
709
7,345
6,932,570.37
2,017
Full Year
State
California
Bydureon
Exenatide Microspheres
949
6,356
5,265,606.7
2,017
Full Year
State
California
Bydureon Pen
Exenatide Microspheres
2,959
29,942
23,561,570.29
2,017
Full Year
State
California
Byetta
Exenatide
1,452
8,153
7,507,499.18
2,017
Full Year
State
California
Trulicity
Dulaglutide
4,126
67,533
55,494,630.2
2,017
Full Year
State
California
Victoza 2-Pak
Liraglutide
3,997
28,736
18,145,771.97
2,017
Full Year
State
California
Victoza 3-Pak
Liraglutide
5,644
70,920
73,640,116.47
2,017
Full Year
State
California
Xultophy 100-3.6
Insulin Degludec/Liraglutide
133
565
519,591.91
2,017
Full Year
State
Colorado
Bydureon
Exenatide Microspheres
135
832
722,932.34
2,017
Full Year
State
Colorado
Bydureon Pen
Exenatide Microspheres
468
2,829
2,577,171.07
2,017
Full Year
State
Colorado
Byetta
Exenatide
368
1,599
1,589,820.31
2,017
Full Year
State
Colorado
Trulicity
Dulaglutide
585
5,389
4,744,228.28
2,017
Full Year
State
Colorado
Victoza 2-Pak
Liraglutide
726
3,841
2,427,518.33
2,017
Full Year
State
Colorado
Victoza 3-Pak
Liraglutide
1,034
8,537
9,239,761.45
2,017
Full Year
State
Connecticut
Bydureon
Exenatide Microspheres
89
505
448,058.97
2,017
Full Year
State
Connecticut
Bydureon Pen
Exenatide Microspheres
345
2,611
2,166,474.48
2,017
Full Year
State
Connecticut
Byetta
Exenatide
207
1,153
1,225,563.47
2,017
Full Year
State
Connecticut
Trulicity
Dulaglutide
592
8,045
7,315,192.66
2,017
Full Year
State
Connecticut
Victoza 2-Pak
Liraglutide
673
4,372
2,869,482.22
2,017
Full Year
State
Connecticut
Victoza 3-Pak
Liraglutide
998
14,159
16,967,661.11
2,017
Full Year
State
Connecticut
Xultophy 100-3.6
Insulin Degludec/Liraglutide
20
52
59,261.47
2,017
Full Year
State
Delaware
Bydureon
Exenatide Microspheres
29
146
159,427.61
2,017
Full Year
State
Delaware
Bydureon Pen
Exenatide Microspheres
118
1,004
1,016,184.09
2,017
Full Year
State
Delaware
Byetta
Exenatide
71
360
428,407.07
2,017
Full Year
State
Delaware
Trulicity
Dulaglutide
250
3,873
4,074,168.53
2,017
Full Year
State
Delaware
Victoza 2-Pak
Liraglutide
151
880
609,492.09
2,017
Full Year
State
Delaware
Victoza 3-Pak
Liraglutide
241
3,731
5,293,706.13
2,017
Full Year
State
Delaware
Xultophy 100-3.6
Insulin Degludec/Liraglutide
18
40
46,606.94
2,017
Full Year
State
District of Columbia
Bydureon
Exenatide Microspheres
19
73
59,469.92
2,017
Full Year
State
District of Columbia
Bydureon Pen
Exenatide Microspheres
76
499
370,168.35
2,017
Full Year
State
District of Columbia
Byetta
Exenatide
24
113
97,972.73
2,017
Full Year
State
District of Columbia
Trulicity
Dulaglutide
116
1,181
1,022,589.91
2,017
Full Year
State
District of Columbia
Victoza 2-Pak
Liraglutide
82
321
205,989.76
2,017
Full Year
State
District of Columbia
Victoza 3-Pak
Liraglutide
153
1,293
1,384,872.63
2,017
Full Year
State
Florida
Bydureon
Exenatide Microspheres
661
3,768
3,302,296.19
2,017
Full Year
State
Florida
Bydureon Pen
Exenatide Microspheres
2,138
20,467
17,122,808.27
2,017
Full Year
State
Florida
Byetta
Exenatide
1,037
4,712
4,751,403.56
2,017
Full Year
State
Florida
Trulicity
Dulaglutide
3,604
47,466
44,015,881.65
2,017
Full Year
State
Florida
Victoza 2-Pak
Liraglutide
3,497
23,754
15,977,785.24
2,017
Full Year
State
Florida
Victoza 3-Pak
Liraglutide
4,850
50,518
58,600,193.14
2,017
Full Year
State
Florida
Xultophy 100-3.6
Insulin Degludec/Liraglutide
30
67
81,744.66
2,017
Full Year
State
Georgia
Bydureon
Exenatide Microspheres
379
2,396
1,873,158.96
2,017
Full Year
State
Georgia
Bydureon Pen
Exenatide Microspheres
1,080
9,426
7,217,543.82
2,017
Full Year
State
Georgia
Byetta
Exenatide
516
2,801
2,576,417.16
2,017
Full Year
State
Georgia
Trulicity
Dulaglutide
2,091
31,705
26,089,603.41
2,017
Full Year
State
Georgia
Victoza 2-Pak
Liraglutide
1,665
11,744
7,337,566.32
2,017
Full Year
State
Georgia
Victoza 3-Pak
Liraglutide
2,215
26,083
27,089,058.9
2,017
Full Year
State
Georgia
Xultophy 100-3.6
Insulin Degludec/Liraglutide
46
104
110,438.58
2,017
Full Year
State
Hawaii
Bydureon
Exenatide Microspheres
37
233
201,266.46
2,017
Full Year
State
Hawaii
Bydureon Pen
Exenatide Microspheres
105
644
609,055.37
2,017
Full Year
State
Hawaii
Byetta
Exenatide
47
307
303,851.95
2,017
Full Year
State
Hawaii
Trulicity
Dulaglutide
209
2,104
2,030,846.02
2,017
Full Year
State
Hawaii
Victoza 2-Pak
Liraglutide
181
1,050
776,177.79
2,017
Full Year
State
Hawaii
Victoza 3-Pak
Liraglutide
331
3,936
5,247,675.99
2,017
Full Year
State
Idaho
Bydureon
Exenatide Microspheres
68
345
281,365.26
2,017
Full Year
State
Idaho
Bydureon Pen
Exenatide Microspheres
257
2,388
1,764,874.66
2,017
Full Year
State
Idaho
Byetta
Exenatide
153
922
838,866.21
2,017
Full Year
State
Idaho
Trulicity
Dulaglutide
319
3,941
3,159,521.67
2,017
Full Year
State
Idaho
Victoza 2-Pak
Liraglutide
384
2,637
1,590,726.01
2,017
Full Year
State
Idaho
Victoza 3-Pak
Liraglutide
485
4,256
4,240,111.27
2,017
Full Year
State
Illinois
Bydureon
Exenatide Microspheres
395
2,289
1,968,747.48
2,017
Full Year
State
Illinois
Bydureon Pen
Exenatide Microspheres
1,150
10,265
8,484,051.59
2,017
Full Year
State
Illinois
Byetta
Exenatide
718
3,978
3,839,078.16
2,017
Full Year
State
Illinois
Trulicity
Dulaglutide
1,711
18,780
15,971,962.77
2,017
Full Year
State
Illinois
Victoza 2-Pak
Liraglutide
1,937
12,660
8,218,760.34
2,017
Full Year
State
Illinois
Victoza 3-Pak
Liraglutide
2,689
27,754
31,258,189.68
End of preview. Expand in Data Studio

The GLP-1 Spending Explosion (2017-2025)

Everyone's heard about Ozempic, Wegovy, and Mounjaro by now. But how much is Medicare actually spending on these drugs, and how fast is it growing? That's what this dataset is about.

I pulled together state-by-state Medicare Part D spending data on GLP-1 medications going back to 2017, when Ozempic first got FDA approval. The dataset covers all 50 states and territories through 2023 at the state level, plus provisional 2024 and 2025 national totals from the most recent quarterly reports. It's about 3,400 rows, not huge, but pretty rich for trend analysis.

Where the data comes from

Everything here was pulled from public APIs on data.cms.gov, which is CMS's open data site. No login, no API keys, no scraping. I merged two sources:

  1. Medicare Part D Prescribers - by Geography and Drug — this is where the state-level breakdowns come from (2017-2023)
  2. Medicare Quarterly Part D Spending by Drug — this gives us the most recent 2024/2025 year-to-date national totals

If you haven't explored data.cms.gov before, it's worth a look. The APIs are well-documented (data-api-documentation) and there's a lot more spending data beyond what I used here. The Quarterly API is actually part of a larger collection of drug spending datasets that includes Medicaid and Medicare Part B if you want to go broader.

If you're building automated pipelines, you can discover all the available API endpoints programmatically through their data.json catalog (it follows the DCAT-US 1.1 standard).

What's in the file

Column Type Description
Year int 2017 through 2025.
Data_Period_Type string Either Full Year or Partial Year (YTD). The 2024 and 2025 rows are provisional year-to-date rollups from the Quarterly API — they only have national-level totals, no state breakdowns or prescriber counts yet.
Geo_Level string National or State.
Geo_Desc string State or territory name (e.g., "Michigan", "Texas").
Brand_Name string Brand name (Ozempic, Wegovy, Trulicity, etc.).
Generic_Name string Generic name (Semaglutide, Tirzepatide, etc.).
Total_Prescribers float Number of distinct providers who prescribed the drug. Null for the provisional partial-year rows.
Total_Claims float Total prescriptions filled, including refills.
Total_Drug_Cost float Total Medicare Part D spending on the drug.

Things you could do with this

  • Dig into the provider level. Once you spot an interesting state, you can go deeper using the Prescribers - by Provider and Drug API to see which doctors and specialties are actually writing these prescriptions.
  • Project 2025 spending. The 2025 data only covers three quarters so far. What does the full year look like? The growth pattern from 2017-2023 was roughly exponential, but the 2024 jump was massive — a simple linear extrapolation probably won't cut it.
  • State-level forecasting. Which states are on track to cross $1B in GLP-1 spending first? There's seven years of adoption data here to work with.
  • Cross-reference with health data. Match states against CDC obesity prevalence or diabetes rates to see whether prescribing patterns actually follow the disease burden.

Ideas for AI and LLM projects

The data.cms.gov catalog is a good fit for a few AI related use cases:

  • RAG for healthcare economics. LLMs aren't great at precise financial figures. You could use the CMS APIs as a retrieval backend so an agent can answer things like "How much did Medicare spend on Ozempic in Michigan in 2023?" with real numbers instead of hallucinated ones.
  • Natural language to API queries. The CMS API supports filters, pagination, and sorting. You could fine-tune a model to translate plain English questions into the right API calls.
  • Benchmarking data agents. This dataset is a good test case for tools like PandasAI or LangChain DataFrame agents — give an agent the CSV and see if it can figure out the 2024 spending spike on its own.

Quick start

import pandas as pd

df = pd.read_csv("geospatial_glp1_spending_2017_2025.csv")

# State-level data for 2023
states_2023 = df[(df['Year'] == 2023) & (df['Geo_Level'] == 'State')]

# Ozempic spending in Michigan
 mi_ozempic = states_2023[(states_2023['Geo_Desc'] == 'Michigan') & (states_2023['Brand_Name'] == 'Ozempic')]
print(f"Michigan Ozempic Spending (2023): ${mi_ozempic['Total_Drug_Cost'].values[0]:,.2f}")
Downloads last month
57